On October 14, JD HEALTH rose 3.15% in Regular Trading, trading at HK$37.34, with turnover of HK$183 million.
The move coincided with market attention on the company’s newly established comprehensive outpatient clinic entity in Beijing’s Lize area, a development linked to its broader push to extend internet healthcare services and build an integrated consultation, diagnosis, medicine and health-management ecosystem.
Recent public filings and company updates show the new unit carries registered capital of RMB5 million and is wholly owned by a JD HEALTH subsidiary. That expansion comes after the company reported first-half revenue of RMB40.888 billion, up 15.9% year over year, with non-IFRS operating profit of about RMB3.48 billion, up 40.3%. Earlier in the month, the company also disclosed that its share capital remained unchanged through September, indicating no material issuance or repurchase activity.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments